Maxcyte MXCT
NASDAQ MXCT
$1.30 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Maxcyte (MXCT) Restructuring Costs (2025)

Updated

Maxcyte's Restructuring Costs came in at $3.06 million for FY2025.

Analysis

Maxcyte (MXCT) Restructuring Costs (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.93 Bn 230.96 Bn 4.88 Bn
2 Abbott Laboratories 181.29 Bn 151.72 Bn 7.27 Bn
3 Danaher 158.18 Bn 141.99 Bn 3.61 Bn
4 Intuitive Surgical 153.47 Bn 132.89 Bn 1.96 Bn
5 Medtronic 118.97 Bn 84.22 Bn 6.34 Bn
6 Stryker 114.72 Bn 100.84 Bn 4.50 Bn
7 Boston Scientific 66.18 Bn 60.95 Bn 3.85 Bn
8 Becton Dickinson 52.49 Bn 49.64 Bn 2.32 Bn
9 Edwards Lifesciences 50.32 Bn 34.33 Bn 1.35 Bn
10 Maxcyte 138.87 Mn -282.45 Mn 5.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 3.06 Mn
API Access

Maxcyte Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=MXCT&period=max&api_key=YOUR_API_KEY